The Tata Capital Healthcare Fund (‘TCHF’) is a growth oriented private equity fund focused on the healthcare and lifesciences sector in India. The fund is sponsored by Tata Capital Limited, a subsidiary of Tata Sons Limited. TCHF has raised ~ US$ 200 million across two funds - TCHF I (2012) and TCHF II (2022). Across both the funds, TCHF has invested in 14 companies, and has successfully exited 5 companies thus far.
TCHF has a talented and diverse team with rich experience across pharmaceutical research, private equity, investment banking, equity research and operations. It is uniquely positioned to partner and support in scaling of healthcare and lifesciences businesses in India by focusing on an all-round approach – from deal sourcing, monitoring and value maximization to delivering exits.
TCHF’s successful track record of investments across two funds and exits from TCHF I stems from the fund’s ability to source differentiated deal flows, build robust diligence processes and formulate plans to ultimately deliver the best exits for investors; thereby maximizing returns for all stakeholders.
TCHF has been awarded ‘Healthcare Investor of the Year’ for three consecutive years (2018, 2019 and 2020) by Venture Intelligence.
Key Fund Highlights
TCHF I (Vintage: 2012) and TCHF II (Vintage: 2020)
Combined Investing and Operating experience
13 Team members
Across investing, operations & advisors
14 Investments and 6 Exits
Across both fund vintages
Total Funds Raised
Marquee international and domestic healthcare investors
Healthcare Investor of the Year
For 3 consecutive years (2018, 2019 and 2020) by Venture Intelligence